Shares of Charles River Laboratories International Inc. CRL slipped 3.37% to $115.41 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.

Lab services company Charles River Laboratories (NYSE:CRL) reported Q1 CY2025 results , but sales fell by 2.7% year on year to $984.2 million. Its non-GAAP profit of $2.34 per share was 12.8% above analysts’ consensus estimates.